Advancing Biopharmaceuticals
and Medical Technologies
in Cardiovascular Medicine

The ability to steer through changes and skillfully manage a transition to another Contract Research Organization (CRO) is sometimes essential for progress in the dynamic field of cardiovascular research. CROs are indispensable; they accelerate the translation of innovative cardiovascular therapies...

Phase 1 clinical studies are the initial step in drug development, designed to assess the safety and tolerability of a new molecule in humans. Traditionally investigational medicinal products (IMP) were tested in multiple Phase 1 clinical trials that enrolled large...

Insights into best practices and efficiency improvement in clinical trials highlight the importance of thorough site identification and selection in the field of cardiovascular research. Managing the complex regulatory environment requires well-thought-out document management and early engagement with regulatory authorities....